Patient info Open main menu

Emselex 7.5 mg prolonged-release tablets (darifenacin) – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
7.5 mg
Other strengths and forms:
Contains active substance:

Patient leaflet - Emselex 7.5 mg prolonged-release tablets

What Emselex is and what it is used for

How Emselex works

Emselex reduces the activity of an overactive bladder. This enables you to wait longer before you go to the toilet and it increases the amount of urine that your bladder can hold.

What Emselex can be used for

Emselex belongs to a class of medicines which relax the muscles of the bladder. It is used in adults for the treatment of the symptoms of overactive bladder conditions - such as a sudden urge to rush to the toilet, needing to go to the toilet frequently and/or not getting to the toilet in time and wetting yourself (urge incontinence).

2

What you need to know before you take Emselex

Other medicines and Emselex

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is particularly important if you are taking any of the following as your doctor may need to adjust your dose of Emselex and/or the other medicine: * certain antibiotics (e.g. erythromycin, clarithromycin, telithromycin and rifampicin),

* antifungal medicines (e.g. ketoconazole and itraconazole - see paragraph “Do not take Emselex”, fluconazole, terbinafine),

* medicines used to reduce the activity of the immune system, for example, after organ transplantation (e.g. ciclosporin - see paragraph “Do not take Emselex”),

* antiviral medicines (e.g. ritonavir - see paragraph “Do not take Emselex”), * antipsychotic medicines (e.g. thioridazine),

* certain antidepressants (e.g. imipramine and paroxetine), * certain anticonvulsants (carbamazepine, barbiturates),

* certain medicines used to treat heart problems (e.g. verapamil - see paragraph “Do not take Emselex”, flecainide, digoxin and quinidine), * certain medicines used for the treatment of stomach problems (e.g. cimetidine),

* other antimuscarinic medicines (e.g. tolterodine, oxybutynin and flavoxate). Please also inform your doctor if you are taking products containing St John’s wort.

Do not take Emselex

* if you are allergic to darifenacin or any of the other ingredients of this medicine (listed in section 6).

* if you suffer from urinary retention (inability to empty your bladder). * if you have gastric retention (problems emptying the contents of the stomach).

* if you suffer from uncontrolled narrow-angle glaucoma (high pressure in the eyes that is not being adequately treated).

* if you have myasthenia gravis (a disease marked by unusual tiredness and weakness of selected muscles).

* if you have severe ulcerative colitis or toxic megacolon (acute dilation of the colon due to complication of infection or inflammation). * if you have severe liver problems.

* if you are taking medicines that strongly decrease the activity of some liver enzymes such as ciclosporin (a medicine used in transplantation to prevent organ rejection or for other conditions, e.g. rheumatoid arthritis or atopic dermatitis), verapamil (a medicine used to lower blood pressure, to correct heart rhythm or to treat angina pectoris), antifungal medicines (e.g. ketoconazole and itraconazole) and some antiviral medicines (e.g. ritonavir) - see paragraph “Other medicines and Emselex”.

Emselex with food and drink

Eating food has no effect on Emselex. Grapefruit juice may interact with Emselex. Tell your doctor if you are taking grapefruit juice regularly.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

Emselex is not recommended during pregnancy.

Emselex should be taken with caution while breast-feeding.

Driving and using machines

Emselex may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness.

If you have any of these symptoms whilst taking Emselex, consult your doctor for advice on changing the dose or considering an alternative treatment. You should not drive or use machines if you are affected by these symptoms. For Emselex, these side effects have been reported to be uncommon (see section 4).

Warnings and precautions

Talk to your doctor before taking Emselex

* if you have autonomic neuropathy (damage to the nerves that communicate between the brain and internal organs, muscles, skin, and blood vessels to regulate vital functions, including the heart rate, blood pressure and bowel function) – your doctor will have told you if you have this. * if you have a condition where one or more organs in your abdomen has moved up into your chest through a hole in your diaphragm, causing you to get heartburn and belch a lot.

* if you have difficulties in passing urine and a weak stream of urine. * if you have severe constipation (less than or equal to 2 bowel movements per week).

* if you have a digestive motility disorder.

* if you have an obstructive gastrointestinal disorder (any obstruction of the passage of intestinal or gastric contents, such as narrowing of the pylorus, the lower part of the stomach) – your doctor will have told you if you have this.

* if you are taking medicinal products that can cause or worsen inflammation of the oesophagus such as oral bisphosphonates (a class of medicinal products that prevent the loss of bone mass and are used to treat osteoporosis).

3

How to take Emselex

Always take Emselex exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. If you have the impression that the effect of Emselex is too strong or too weak, talk to your doctor or pharmacist.

How much Emselex to take

The recommended starting dose, including for patients aged over 65 years, is 7.5 mg daily. Depending on your response to Emselex, your doctor may increase your dose to 15 mg daily, two weeks after starting therapy.

These doses are suitable for people with mild liver problems or people with kidney problems.

Take Emselex tablets once a day with liquid, at about the same time each day.

The tablet may be taken with or without food. Swallow the tablet whole. Do not chew, split or crush it.

®

Emselex 7.5 mg prolonged-release tablets (darifenacin)

Patient Information Leaflet (continued)

If you take more Emselex than you should

If you have taken more tablets than you have been told to take, or if someone else accidentally takes your tablets, go to your doctor or hospital for advice immediately. When seeking medical advice, make sure that you take this leaflet and your remaining tablets with you to show them to the doctor. People who have taken an overdose may have dry mouth, constipation, headache, indigestion and nasal dryness. Overdose with Emselex may lead to severe symptoms requiring emergency treatment in hospital.

If you forget to take Emselex

If you forget to take Emselex at the usual time, take it as soon as you remember, unless it is the time for your next dose. Do not take a double dose to make up for a forgotten dose.

If you stop taking Emselex

Your doctor will tell you how long your treatment with Emselex will last. Do not stop treatment early because you do not see an immediate effect. Your bladder will need some time to adapt.

Finish the course of treatment prescribed by your doctor. If you have not noticed any effect by then, discuss it with your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects caused by Emselex are usually mild and temporary.

Some side effects could be serious

Not known (frequency cannot be estimated from the available data)

Serious allergic reactions including swelling, mainly of the face and neck (angioedema).

Other side effects

Very common (may affect more than 1 in 10 people)

Dry mouth, constipation.

Common (may affect up to 1 in 10 people)

Headache, abdominal pain, indigestion, feeling sick, dry eyes, nasal dryness.

Uncommon (may affect up to 1 in 100 people)

Fatigue, accidental injury, facial swelling, high blood pressure, diarrhoea, flatulence, ulceration of the mucous membrane of the mouth, increased liver enzymes (this shows abnormal functioning of the liver), swelling including swelling of the hands, ankles or feet, dizziness, sleeplessness, drowsiness, abnormal thinking, runny nose (rhinitis), cough, shortness of breath, dry skin, itching, rash, sweating, visual disturbance including blurred vision, taste disturbance, urinary tract disorder or infection, impotence, discharge and itching in the vagina, bladder pain, inability to empty your bladder.

Not known (frequency cannot be estimated from the available data)

Confusion, depressed mood/mood altered, hallucination, muscle spasms.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system:

Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5

How to store Emselex

Do not use Emselex after the expiry date which is stated on the carton/blister/label after EXP. The expiry date refers to the last day of the month.

Keep the blister packs in the outer carton in order to protect from light.

Do not use if the pack is damaged or shows signs of tampering.

If your doctor tells you to stop taking this medicine, return any unused tablets to your pharmacist (chemist) for safe disposal. Only keep this medicine if your doctor tells you to.

If the tablet becomes discoloured or shows any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do. Medicines should not be disposed of via wastewater or household waste.

Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6

Contents of the pack and other information

What Emselex contains

* The active substance is darifenacin. Each tablet contains 7.5 mg darifenacin (as hydrobromide).

* The other ingredients are calcium hydrogen phosphate (anhydrous), hypromellose, magnesium stearate, polyethylene glycol, titanium dioxide (E171) and talc.

What this medicine looks like and contents of the pack

Emselex 7.5 mg prolonged-release tablets are round, convex white tablets and are debossed with “DF” on one side and “7.5” on the other.

The tablets are available in blister packs containing 28 tablets.

Manufacturer and Licence Holder

This medicine is manufactured by Norgine B. V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, The Netherlands and is procured from within the EU and repackaged by the Product Licence Holder: Lexon (UK) Limited, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE.

If you have any questions or are not sure about anything, ask your doctor or pharmacist. They will have additional information about this medicine and will be able to advise you.

PL 15184/2155 Emselex 7.5mg prolonged-release tablets

Ref: 2155/050626/B/1 POM

Emselex is a registered trademark of pharmaand GmbH

Leaflet revision date: 05/06/2026

Blind or partially sighted?

Is this leaflet hard to see or read? Phone Lexon (UK) Limited, Tel: 01527 505414 to obtain the leaflet in a format suitable for you

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 15184/2155

Last revision stated in the text: 5 June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Emselex 7.5 mg prolonged-release tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Darifenacin
Strength 7.5 mg
Pharmaceutical form Modified-release tablet
White round, convex tablet, debossed with “DF” on one side and “7.5” on the reverse.
How is it taken Oral
Excipients Calcium hydrogen phosphate, anhydrous, Hypromellose, Magnesium stearate, Polyethylene glycol, Titanium dioxide (E171), Talc
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage Keep the blister packs in the outer carton in order to protect from light.
Drug group (ATC) Urologicals, drugs for urinary frequency and incontinence
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD10 darifenacin
Marketing authorisation PLGB 54599/0002 (first authorised 1 January 2021), PLPI 15184/2155
Marketing authorisation holder pharmaand GmbH
Codes GTIN 9120099673822 · BNF 07040200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.